These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3509755)

  • 1. HLA antigens in Sicilian patients affected by chronic myelogenous leukaemia.
    Caruso C; Lo Campo P; Botindari C; Modica MA
    J Immunogenet; 1987 Dec; 14(6):295-9. PubMed ID: 3509755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA system affects the age-at-onset in chronic myeloid leukemia.
    Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
    Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and analysis of HLA-A, B and DRB1 genes in patients with chronic myelogenous leukemia in Guangdong area].
    Wei L; Xiao LL; Wu XY; Lin Q; Dong M; Wen JY; Ma XK; Chong F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):915-8. PubMed ID: 18718089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is HLA-DR4 or the HLA-DRB1*0402 allele associated with decreased risk for CML?
    Pawelec G; Wagner W
    Leukemia; 2001 Jan; 15(1):192-3. PubMed ID: 11243394
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogenous leukemia.
    Yasukawa M; Ohminami H; Kojima K; Inokuchi K; Nishimura Y; Fujita S
    Am J Hematol; 2000 Feb; 63(2):99-101. PubMed ID: 10629577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA and leukemia].
    Baldauf C; Kubel M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):123-32. PubMed ID: 2472315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA risk markers for chronic myelogenous leukemia in Eastern Canada.
    Naugler C; Liwski R
    Leuk Lymphoma; 2009 Feb; 50(2):254-9. PubMed ID: 19235017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia.
    Mizuno S; Emi N; Kasai M; Ishitani A; Saito H
    Br J Haematol; 2000 Oct; 111(1):280-2. PubMed ID: 11091213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigens in Indian patients with chronic myeloid leukemia.
    Chhaya SU
    Leuk Lymphoma; 2006 Feb; 47(2):291-5. PubMed ID: 16321860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigens in 295 Chinese patients with chronic myeloid leukemia.
    Miao KR; Pan QQ; Xue M; Fan S; Wang XY; Pan M; Zhou XY; Fei XM; Zhao X; Wang CY
    Leuk Lymphoma; 2007 Nov; 48(11):2152-6. PubMed ID: 17926184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic Polymorphisms of
    Ureshino H; Shindo T; Kojima H; Kusunoki Y; Miyazaki Y; Tanaka H; Saji H; Kawaguchi A; Kimura S
    Cancer Immunol Res; 2018 Jun; 6(6):745-754. PubMed ID: 29695383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
    Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
    J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.
    Posthuma EF; Falkenburg JH; Apperley JF; Gratwohl A; Hertenstein B; Schipper RF; Oudshoorn M; Biezen JH; Hermans J; Willemze R; Roosnek E; Niederwieser D
    Leukemia; 2000 May; 14(5):859-62. PubMed ID: 10803518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible association of juvenile myoclonic epilepsy with HLA-DRw6.
    Durner M; Janz D; Zingsem J; Greenberg DA
    Epilepsia; 1992; 33(5):814-6. PubMed ID: 1396421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenetic markers in hemoblastosis].
    Zaretskaia IuM; Khamaganova EG; Aleshchenko SM; Pivnik AV
    Ter Arkh; 2000; 72(12):54-7. PubMed ID: 11201835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia.
    Clark RE; Christmas SE
    Leuk Lymphoma; 2001; 42(5):871-80. PubMed ID: 11697642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA class I-CML association revisited taking into account the two forms of gene fusion in the Philadelphia chromosome. A multicenter study.
    Richiardi PM; Tosi R; Martinelli G; Saglio G; Conte R; Barbanti M; Dall'Omo A; Farabegoli P; Favoino B; Gambelunghe C
    Leukemia; 1994 Dec; 8(12):2134-7. PubMed ID: 7808001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A,B,C and DR antigens in a sample of the Tunisian population.
    Ayed K; Bardi R; Gebuhrer L; Gorgi Y; Betuel H
    Tissue Antigens; 1987 May; 29(5):225-31. PubMed ID: 3660397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.